VentureBeat August 15, 2024
Bryson Masse

Caresyntax has raised $180 million in a Series C extension and debt financing round, the company announced today, further fueling the development and marketing of its “surgical intelligence platform,” a software-as-a-service (Saas) offering that seeks to improve surgery outcomes for patients by connecting the entire surgery process through tech — from booking staff to monitoring the surgery with close-up video to providing analytics about surgery outcomes and costs.

The platform can even connect to other existing robotic surgery tools and equipment found in operating rooms around the world.

Now, the new funding funding builds on Caresyntax’s previous $130 million Series C from 2021 and other sources, bringing its total funding to around $400 million since its founding in 2013.

VentureBeat...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Investments, Medical Devices, Technology, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article